PIK-001

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NamePIK-001
Drug Alias NamePIK-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action1-phosphatidylinositol 3-phosphate 5-kinase inhibitors
Targets1-phosphatidylinositol 3-phosphate 5-kinase
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Toronto, Toronto
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Toronto, Toronto
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A